WallStreetZenWallStreetZen

NASDAQ: IGMS
Igm Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IGMS

Based on 8 analysts offering 12 month price targets for Igm Biosciences Inc

Min Forecast
$1.50+0%
Avg Forecast
$6.50+333.33%
Max Forecast
$22.00+1,366.67%

Should I buy or sell IGMS stock?

Based on 8 analysts offering ratings for Igm Biosciences Inc.

Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 12.5%
Hold
6 analysts 75%
Sell
0 analysts 0%
Strong Sell
1 analysts 12.5%
Although IGMS's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates IGMS as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their IGMS stock forecasts and price targets.

IGMS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-10
lockedlocked$00.00+00.00%2025-01-10
lockedlocked$00.00+00.00%2025-01-10
lockedlocked$00.00+00.00%2025-01-10
lockedlocked$00.00+00.00%2025-01-10
Anonymous
Guggenheim
Strong BuyMaintains$20.00+1,233.33%2024-10-01
Wedbush
Top 14%
87
BuyMaintains$22.00+1,366.67%2024-10-01
JP Morgan
Bottom 4%
4
Strong SellDowngrades$9.00+500.00%2024-10-01
HC Wainwright & Co.
Bottom 1%
1
HoldMaintains$11.00+633.33%2024-09-05

1 of 1

Forecast return on equity

Is IGMS forecast to generate an efficient return?

Company
4.27%
Industry
235.73%
Market
89.8%
IGMS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IGMS forecast to generate an efficient return on assets?

Company
1.11%
Industry
34.61%
IGMS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IGMS earnings per share forecast

What is IGMS's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$0.96
Avg 2 year Forecast
-$0.37
Avg 3 year Forecast
$0.01

IGMS revenue forecast

What is IGMS's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$12.5M+329.64%
Avg 2 year Forecast
$34.8M+1,094.17%
Avg 3 year Forecast
$25.5M+774.09%
IGMS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IGMS revenue growth forecast

How is IGMS forecast to perform vs Biotechnology companies and vs the US market?

Company
122.56%
Industry
49.33%
Market
11.84%
IGMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IGMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IGMS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IGMS$1.50$6.50+333.33%Hold
ORMP$2.21N/AN/A
ADVM$4.32$26.67+517.29%Buy
ABOS$1.47$10.50+614.29%Strong Buy
IMUX$0.98$9.50+869.39%Strong Buy
View Top Biotech Stocks

Igm Biosciences Stock Forecast FAQ

Is Igm Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: IGMS) stock is to Hold IGMS stock.

Out of 8 analysts, 0 (0%) are recommending IGMS as a Strong Buy, 1 (12.5%) are recommending IGMS as a Buy, 6 (75%) are recommending IGMS as a Hold, 0 (0%) are recommending IGMS as a Sell, and 1 (12.5%) are recommending IGMS as a Strong Sell.

If you're new to stock investing, here's how to buy Igm Biosciences stock.

What is IGMS's earnings growth forecast for 2025-2027?

(NASDAQ: IGMS) Igm Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.98%.

Igm Biosciences's earnings in 2025 is -$219,843,000.On average, 7 Wall Street analysts forecast IGMS's earnings for 2025 to be -$57,002,364, with the lowest IGMS earnings forecast at -$121,306,929, and the highest IGMS earnings forecast at -$5,351,776. On average, 5 Wall Street analysts forecast IGMS's earnings for 2026 to be -$22,120,675, with the lowest IGMS earnings forecast at -$65,410,599, and the highest IGMS earnings forecast at $0.

In 2027, IGMS is forecast to generate $594,642 in earnings, with the lowest earnings forecast at -$7,135,702 and the highest earnings forecast at $11,298,194.

What is IGMS's revenue growth forecast for 2025-2027?

(NASDAQ: IGMS) Igm Biosciences's forecast annual revenue growth rate of 122.56% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.84%.

Igm Biosciences's revenue in 2025 is $2,918,000.On average, 4 Wall Street analysts forecast IGMS's revenue for 2025 to be $745,502,437, with the lowest IGMS revenue forecast at $104,062,317, and the highest IGMS revenue forecast at $1,406,327,881. On average, 4 Wall Street analysts forecast IGMS's revenue for 2026 to be $2,072,088,851, with the lowest IGMS revenue forecast at $255,101,336, and the highest IGMS revenue forecast at $4,738,938,441.

In 2027, IGMS is forecast to generate $1,516,693,401 in revenue, with the lowest revenue forecast at $319,322,652 and the highest revenue forecast at $2,824,548,598.

What is IGMS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: IGMS) forecast ROA is 1.11%, which is lower than the forecast US Biotechnology industry average of 34.61%.

What is IGMS's Price Target?

According to 8 Wall Street analysts that have issued a 1 year IGMS price target, the average IGMS price target is $6.50, with the highest IGMS stock price forecast at $22.00 and the lowest IGMS stock price forecast at $1.50.

On average, Wall Street analysts predict that Igm Biosciences's share price could reach $6.50 by Jan 10, 2026. The average Igm Biosciences stock price prediction forecasts a potential upside of 333.33% from the current IGMS share price of $1.50.

What is IGMS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IGMS) Igm Biosciences's current Earnings Per Share (EPS) is -$3.61. On average, analysts forecast that IGMS's EPS will be -$0.96 for 2025, with the lowest EPS forecast at -$2.04, and the highest EPS forecast at -$0.09. On average, analysts forecast that IGMS's EPS will be -$0.37 for 2026, with the lowest EPS forecast at -$1.10, and the highest EPS forecast at $0.00. In 2027, IGMS's EPS is forecast to hit $0.01 (min: -$0.12, max: $0.19).

What is IGMS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: IGMS) forecast ROE is 4.27%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.